Table 1.
Sociodemographic and clinical characteristics of PLHIV initiated on ART in six ART clinics operated by AIDS/STI teams in Yangon Region during January to December 2017
| Characteristics | N (%)* |
| Total | 567 (100) |
| Age in years | |
| 15–29 | 190 (33.5) |
| 30–44 | 278 (49.0) |
| 45–59 | 90 (15.9) |
| 60 and above | 9 (1.6) |
| Gender | |
| Male | 325 (57.3) |
| Female | 242 (42.7) |
| Employment | |
| Yes | 398 (70.2) |
| No | 138 (24.3) |
| Not recorded | 31 (5.5) |
| Literate | |
| Yes | 505 (89.1) |
| No | 47 (8.3) |
| Not recorded | 15 (2.7) |
| Marital status | |
| Single | 148 (26.1) |
| Married | 283 (49.9) |
| Widow | 58 (10.2) |
| Divorced/separated | 57 (10.1) |
| Not recorded | 21 (3.7) |
| Clinic | |
| Clinic A | 272 (48.0) |
| Clinic B | 123 (21.7) |
| Clinic C | 21 (3.7) |
| Clinic D | 30 (5.3) |
| Clinic E | 39 (6.9) |
| Clinic F | 82 (14.5) |
| WHO clinical staging | |
| Stage 1 | 236 (41.6) |
| Stage 2 | 148 (26.1) |
| Stage 3 | 160 (28.2) |
| Stage 4 | 23 (4.1) |
| CD4 count (cells/mm3) | |
| 0–199 | 208 (36.7) |
| 200–349 | 114 (20.1) |
| 350–499 | 118 (20.8) |
| >500 | 116 (20.5) |
| Missing | 11 (1.9) |
| ART regimen | |
| TDF+3TC+EFV | 558 (98.4) |
| Other first line regimen | 9 (1.6) |
*Column percentage.
ART, antiretroviral therapy; CD4, cluster of differentiation 4/CD4+T helper cells; EFV, efavirenz; PLHIV, people living with HIV/AIDS; STI, sexually transmitted infection; 3TC, lamivudine; TDF, tenofovir.